NEWSROOM

Blog

Formation Minerals, Inc. Provides Fiscal Year End Corporate Update

Formation Minerals, Inc. Provides Fiscal Year End Corporate Update

Aug 14, 2024

Jacksboro, Texas, August 14, 2024 – Formation Minerals, Inc. (OTCQB: FOMI) (“Formation” or the “Company”), a growing oil and gas company with a focus on the acquisition and management of oil and gas minerals and royalties, today provided its fiscal year-end stockholder update. To our valued friends and stockholders, We hope that this letter finds you well and enjoying the summer. We at Formation continue to execute our strategy and are pleased to provide a corporate update in connection with...

Metatron Announces QuantumBeam – A Revolution in AI-Controlled Energy Transmission

Metatron Announces QuantumBeam – A Revolution in AI-Controlled Energy Transmission

Aug 13, 2024

Dover, DE, August 13th, 2024 – Metatron Apps Inc (OTC: MRNJ) ($MRNJ), leading developer of over 1000 mobile apps proudly introduces QuantumBeam, a groundbreaking service that harnesses AI-designed and controlled cloud technology to deliver continuous energy transmission through quantum entanglement. This cutting-edge platform offers unparalleled benefits such as enhanced vitality, stress reduction, and EMF mitigation, backed by rigorous scientific studies demonstrating its effectiveness....

Sono-Tek Announces Additional $2.95 Million Order from Specialty Clean Energy Customer

Sono-Tek Announces Additional $2.95 Million Order from Specialty Clean Energy Customer

Aug 13, 2024

4 System Order Expected to be Shipped in Fiscal 2026 Company Experiencing Strong Demand from Clean Energy Sector MILTON, NY, August 13, 2024 — Sono-Tek Corporation (Nasdaq: SOTK), a leading developer and manufacturer of ultrasonic coating systems, is pleased to announce the receipt of an additional $2.95 million order from an existing clean energy customer. This new order, identical in value and scope to a recent record-breaking order from the same customer, reinforces Sono-Tek’s position as a...

Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study

Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study

Aug 12, 2024

Case Series represents second study showing VitaGraft Kidney as a measure of response to the benefit of therapy for one leading cause of allograft failure IRVINE, Calif., August 12, 2024 — Oncocyte Corp. (Nasdaq: OCX), a molecular diagnostics technology company, announced the recent publication of a case series of two kidney transplant patients who were monitored for antibody-mediated rejection (AMR) using its proprietary VitaGraft™ Kidney diagnostic test. Patients were tested before, during...

BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million

BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million

Aug 12, 2024

Company reports transformative second-quarter revenue, contributing to a record total of $116.4 million in revenue for the first half of 2024 AmnioWrap2 continues to be a major growth driver achieving an impressive 56.5% sequential revenue increase compared to Q1 2024 Achieves second consecutive quarter of positive net income with $6.3 million Generated Adjusted Q2 2024 EBITDA of $10.0 million Financial Results Conference Call and Webcast on Monday, August 12, 2024, at 4:30 pm EDT POMPANO...

SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products

SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products

Aug 12, 2024

MIAMI, FL, August 12, 2024 – SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with over 97 pending and issued patents globally and over 60 lighting and home décor websites, with a mission to make homes and buildings become safe and smart as the new standard, today reported its financial and operational results for the second quarter ended June 30, 2024. Second Quarter 2024 and Recent Achievements Generated...

AB INTL GROUP Reports of Financial Results for period ending May 31, 2024 and achieved Net Profitability

AB INTL GROUP Reports of Financial Results for period ending May 31, 2024 and achieved Net Profitability

Aug 12, 2024

NEW YORK, August 12, 2024 -- AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, announces its financial results for the period ended May 31, 2024. The financial results have been filed in a 10-Q with the U.S. Securities and Exchange Commission (the "SEC"). Key Financial Highlights: Revenues for the three months ended May 31, 2024, increased 22% to $698,311, as compared to $573,389 for the three months ended May 31, 2023. Net income...

StemSation International Provides Corporate Updates

StemSation International Provides Corporate Updates

Aug 12, 2024

StemSation International is providing updates on corporate planning and direction as they execute on an expanded business model Plantation, Florida, August 12, 2024 – StemSation International (OTC: STSN), a South-Florida based company that has licensed technology for the production and distribution of flavored, canned oxygen products is announcing new business initiatives for the upcoming months. "We announced last year that we had streamlined our current business and would be seeking further...

Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

Aug 12, 2024

Top Line Data Expected Year-End 2024 Pittsburgh, August 12, 2024 -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” “we” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces the dosing of the first two patients with LP-310 in its Phase 2a clinical trial in Oral Lichen Planus (OLP) patients. Lipella’s Phase 2a trial is a multicenter, dose-ranging study involving adult male and female subjects...

ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides

ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides

Aug 9, 2024

Melanocortin receptors on neurons in the brain control feeding and weight loss Patented peptide molecules delivered orally as a pill can control feeding disorders and weight loss NEW YORK, NY, August 09, 2024 - ANEW MEDICAL, INC. (NASDAQ: WENA) has announced that, as a result of its worldwide licensing agreement with Teleost Biopharmaceuticals and the University of Arizona, it plans to pursue the development of therapeutics using novel proprietary peptides that selectively bind and activate...

Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study

Oncocyte Announces Successful GraftAssure Beta Launch and Q2 2024 Results

Aug 8, 2024

Interest in kidney transplant assay represents approximately 25% of US transplant volume Company lays out land and expand strategy in transplant IRVINE, Calif., August 8, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published its second quarter 2024 results and the following letter to shareholders. Dear shareholders, We are thrilled to report that we have successfully launched GraftAssureTM, which is our research-use-only assay that can detect...

Premier Graphene President Pedro Mendez Meets with Global Leader in Sustainable Construction

Premier Graphene President Pedro Mendez Meets with Global Leader in Sustainable Construction

Aug 8, 2024

Premier’s Graphene Suspensions Receiving Interest from one of the World’s Largest Materials Handling Companies EL CENTRO, California, August 8, 2024 – Premier Graphene, Inc. (OTC PINK: BIEI) announced today that one of the world’s largest materials handling company invited Premier Graphene to permit them to test and separately confirm HGI's proprietary hemp-based graphene formulation in concrete with respect to which it has a distribution license in the United States. Impressed with the...

ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides

ANEW MEDICAL, INC. Announces Patents Issued in Major Asian Markets for use of Genetic Therapy in the Treatment of Alzheimer’s Disease and ALS

Aug 8, 2024

Patents issued in mainland China protect the Company’s novel secreted Klotho protein and Its gene delivery system Recent Patents issued in Hong Kong and Shanghai support protection to develop treatments for Alzheimer’s Disease and other neurodegenerative diseases New York, NY, August 8, 2024 - ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a US-based biotechnology company focused on developing cell- and gene-based treatments to affect aging and age-related diseases, announces the...

BLAQclouds, Inc. Announces Intent to Acquire ZEUS Blockchain Partners

BLAQclouds, Inc. Announces Intent to Acquire ZEUS Blockchain Partners

Aug 7, 2024

Las Vegas, NV, August 07, 2024 — BLAQclouds, Inc. (OTC: BCDS) is pleased to announce the intent to acquire the equity of ZEUS Blockchain Partners, Inc. through a SAFE Agreement. As part of this process BLAQclouds, Inc. now has a 90-day exclusive period to complete the transaction. ZEUS Blockchain Partners, Inc. has developed https://zeuschainscan.io/, a Layer 1 Ethereum Virtual Machine (EVM) chain, premiered with the ZEUS Token. The ZEUS Token has also been integrated as the settlement token...

SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products

SKYX Announces Corporate Update Call

Aug 7, 2024

Company to Provide Corporate Updates Including Second Quarter 2024 Financial Results; Conference Call to be Held on Monday, August 12, 2024 at 4:30 PM Eastern Time Miami, August 7, 2024 – SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive smart platform technology company with over 97 issued and pending patents in the U.S. and globally, and which owns over 60 lighting and home décor websites with a mission to make homes and buildings become smart, safe, and advanced as the...

Hollywood Star Cuts Expands Through Strategic Agreement With Utah Based Haircare Franchise Group

Hollywood Star Cuts Expands Through Strategic Agreement With Utah Based Haircare Franchise Group

Aug 7, 2024

Las Vegas, NV, August 7, 2024 – All American Gold Corp. (OTC: AAGC) is very excited to update the public about AAGC’s agreement with an existing Hair-Care Franchise group to join the Hollywood Star Cuts family. On August 5th, 2024, Hollywood Star Cuts entered into an agreement with a Utah based group that currently owns and operates twelve (12) full-service family hair salons. These salons are presently being operated under a multi-national franchise brand name. Representatives of the...

American Shared Hospital Services Announces Start of Patient Treatments at its Radiation Therapy Facility, A.B. Radiocirugía y Radioterapia de Puebla, in Puebla, Mexico

American Shared Hospital Services Announces Start of Patient Treatments at its Radiation Therapy Facility, A.B. Radiocirugía y Radioterapia de Puebla, in Puebla, Mexico

Aug 6, 2024

SAN FRANCISCO, CA, August 6, 2024 ‒ American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced that it has begun treating patients at its Radiation Therapy Facility, A.B. Radiocirugía y Radioterapia de Puebla (“A.B.”), in Puebla, Mexico, located 80 miles from Mexico City. AMS has a Joint Venture (“JV”) agreement with the principal...

REMSleep Holdings Inc. Issues Shareholder Letter

REMSleep Holdings Inc. Issues Shareholder Letter

Aug 6, 2024

Company Unveils Internal Corporate Goal of Capturing 10% of the CPAP Mask Market Within 24 Months CLEARWATER, Fla., August 6, 2024 - REMSleep Holdings, Inc. (OTCQB: RMSL), a leader in innovative sleep apnea products, published the following letter to shareholders. Dear REMSleep Shareholders and Interested Investors: Our company’s primary focus is two-fold. First, we are dedicated to providing high-quality products and experiences for CPAP therapy to support our customers and their families....

Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study

Oncocyte Announces August Investor Conferences Participation

Aug 5, 2024

IRVINE, Calif., August 5, 2024 — Oncocyte Corp. (Nasdaq: OCX), a molecular diagnostics technology company, today announced that CEO Josh Riggs and CFO Andrea James plan to participate in the following investor conferences in August: 9th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference, August 12-13, 2024. Oncocyte management plans to host meetings with investors. Sidoti Micro-Cap Virtual Conference, August 14-15, 2024. The company is scheduled to present on Wednesday, August 14,...

BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million

BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024

Aug 5, 2024

Conference Call and Webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., August 5, 2024, — BioStem Technologies, Inc. (OTC: BSEM), a leading medtech company specializing in the development, manufacture, and commercialization of placental-derived allografts for advanced wound care, announced today that it will release its second quarter 2024 financial results after the market close on Monday, August 12, 2024. The company will also host a conference call and webcast at 4:30 PM ET to discuss the...

Vocodia Holdings Announces $2.8 million Preferred Stock Purchase Agreement as part of a $3.0 million Capital Raise

Vocodia Holdings Announces $2.8 million Preferred Stock Purchase Agreement as part of a $3.0 million Capital Raise

Aug 5, 2024

Boca Raton, FL, August 5, 2024 – Vocodia Holdings Corp (CBOE: VHAI) (“Vocodia” or the "Company") a leader in AI software development focusing on practical AI applications, today announced the execution of a Securities Purchase Agreement (the “SPA”) and a Placement Agency Agreement marking a pivotal step in Vocodia’s strategic growth initiatives and capital structure optimization. Under the terms of the SPA, the Company has entered into an agreement with certain accredited investors for the...

Direct Equity Source Announces Strategic Partnership with AAA Storage to Expand Self-Storage Portfolio

Direct Equity Source Announces Strategic Partnership with AAA Storage to Expand Self-Storage Portfolio

Aug 2, 2024

Austin, Texas, August 2, 2024 – Direct Equity Source, a leading real estate private equity firm, is pleased to announce a strategic partnership with AAA Storage, an industry-leading self-storage company. Direct Equity Source, via its recently formed fund, will be the largest single investor in AAA Storage’s current multi-property Growth Fund I, and significantly expand its self-storage portfolio across the United States. This partnership combines Direct Equity Source's extensive experience in...

Vocodia Holdings Announces $2.8 million Preferred Stock Purchase Agreement as part of a $3.0 million Capital Raise

Vocodia’s Demos Offer Human-Like AI Interactions

Aug 2, 2024

Chicago, August 2, 2024 -- Vocodia Holdings Corp. (CBOE: VHAI), a pioneering AI software company specializing in practical AI solutions, today invites the public to try out one of four groundbreaking Conversational AI demos to see how Vocodia’s Digital Intelligent Sales Agents (DISA) actually work. Vocodia’s technology platform harnessed the power of conversational AI and is changing the game for contact centers in all industries and today we are inviting you to take a closer look at DISA and...

Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial

Lipella Pharmaceuticals Announces Closing of $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

Aug 1, 2024

PITTSBURGH, PA, August 1, 2024 – Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has closed its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase and sale of an aggregate of 2,066,000 shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $0.62 per share (or...

Oncocyte to Announce Second Quarter 2024 Financial Results on August 8

Oncocyte to Announce Second Quarter 2024 Financial Results on August 8

Aug 1, 2024

Conference Call and Webcast on Thursday, August 8, 2024 at 2:00 p.m. PT / 5:00 p.m. ET IRVINE, Calif., Aug 1, 2024 - Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, announced today that the company will release its second quarter 2024 financial results on Thursday, August 8, 2024, after U.S. market close. The company will host a conference call and webcast on Thursday, August 8, 2024, at 5:00 p.m. Eastern Time to discuss its financial results and highlights. Interested parties...

SPZI: Bloxcross and JP3E Announce the Global Trade Financing Platform Is Live

SPZI: Bloxcross and JP3E Announce the Global Trade Financing Platform Is Live

Aug 1, 2024

NEW YORK, August 1, 2024 - JP 3E Holdings, Inc. (OTC: SPZI), formerly Spooz, Inc., recently acquired a majority stake in Bloxcross, Inc. In the wake of this significant acquisition, they announce the launch of a new Global Trade Financing Platform, positioning Bloxcross as a key element of the JP3E portfolio. We expect that the Global Trade Financing Platform will make a substantial contribution to the revenue of both JP 3E Holdings and Bloxcross by executing existing commodity contracts....

Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

Lipella Pharmaceuticals Announces $1.28 Million Registered Direct Offering of Common Stock Priced At-the-Market Under Nasdaq Rules

Aug 1, 2024

PITTSBURGH, PA, August 1, 2024 – Lipella Pharmaceuticals Inc. (“Lipella” or the “Company”) (Nasdaq: LIPO), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2,066,000 shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $0.62 per share (or pre-funded warrant in lieu thereof) in a registered direct offering...

PRISM MarketView Launches AI Infrastructure and Datacenter Index

PRISM MarketView Launches AI Infrastructure and Datacenter Index

Aug 1, 2024

New Index Showcases Companies Positioned to Fuel the Booming AI Market NEW YORK, August 01, 2024-- PRISM MarketView, a leading provider of unbiased market insight and company news, today announces the launch of its PRISM Emerging AI Infrastructure and Datacenter Index in response to significant global growth and interest in AI technology. The new PRISM index tracks emerging companies supplying AI-related infrastructure and the datacenters that store this technology. The global AI market...

NATURAL HARMONY FOODS INC. COMPLETES FINANCIAL AUDITS FOR 2022 & 2023

NATURAL HARMONY FOODS INC. COMPLETES FINANCIAL AUDITS FOR 2022 & 2023

Jul 31, 2024

UNLOCKING FUNDS TO ACCELERATE OPERATIONS NEW YORK, NY July 31st, 2024 - Publicly-held Natural Harmony Foods Inc. (OTC: NHYF), is delighted to report the completion of its financial statement audits for the years 2022 and 2023. This accomplishment represents a significant advancement in the Company's corporate governance and will underpin its ongoing operations. It will also assist in removing its current shell status and lay the groundwork for its desired OTCQB listing. The...

Sono-Tek Announces Additional $2.95 Million Order from Specialty Clean Energy Customer

Sono-Tek Announces Largest Order in Company History

Jul 31, 2024

$2.95 Million Order from Specialty Clean Energy Customer Third Part of Expected Multi-System Program 4 System Order Expected to be Shipped in First Half of Fiscal 2026 MILTON, NY, July 31, 2024 - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, is pleased to announce that it has received a significant new order from an existing clean energy customer. The $2.95 million order is the third part of an anticipated multi-system program and is...